Tirzepatide

Tirz is a glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist designed to offer a comprehensive approach to metabolic health. These mechanisms contribute not only to improved glycemic control but also to clinically significant weight loss. Offered as a lyophilized (freeze-dried) powder in a sterile, sealed vial, this high-purity product is intended for laboratory applications, including in vitro and preclinical research. Every batch undergoes stringent quality control processes to ensure reliable consistency, stability, and adherence to research-grade standards

Key Features:

• Purity: ≥99% (confirmed through HPLC analysis).
• Formulation: Lyophilized powder for straightforward reconstitution with sterile solvents.
• Storage: Long-term stability when stored at -20°C (-4°F); protect from light and moisture.
• Packaging: Sealed under vacuum in a sterile glass vial to preserve product integrity.

Intended Use:

Tirzepatide  is intended solely for scientific research purposes, including studies on metabolic pathways, receptor interactions, or cellular responses within controlled laboratory environments. Researchers are responsible for complying with all relevant institutional and governmental regulations concerning the handling of bioactive substances.

Disclaimer: The following information is provided strictly for research purposes only. It is not intended for human or veterinary use outside of approved, controlled studies. Always follow applicable laws, institutional guidelines, and ethical standards.

Additional Research Notes:

• Tirzepatide has a half-life of approximately 5 days → thus, weekly dosing is standard.